<code id='29D0C427ED'></code><style id='29D0C427ED'></style>
    • <acronym id='29D0C427ED'></acronym>
      <center id='29D0C427ED'><center id='29D0C427ED'><tfoot id='29D0C427ED'></tfoot></center><abbr id='29D0C427ED'><dir id='29D0C427ED'><tfoot id='29D0C427ED'></tfoot><noframes id='29D0C427ED'>

    • <optgroup id='29D0C427ED'><strike id='29D0C427ED'><sup id='29D0C427ED'></sup></strike><code id='29D0C427ED'></code></optgroup>
        1. <b id='29D0C427ED'><label id='29D0C427ED'><select id='29D0C427ED'><dt id='29D0C427ED'><span id='29D0C427ED'></span></dt></select></label></b><u id='29D0C427ED'></u>
          <i id='29D0C427ED'><strike id='29D0C427ED'><tt id='29D0C427ED'><pre id='29D0C427ED'></pre></tt></strike></i>

          entertainment

          entertainment

          author:leisure time    Page View:87655
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Stop Congress from blocking public access to science
          Stop Congress from blocking public access to science

          AdobeHaveyoueverneededtoreadaresearchpaper,onlytofinditwaslockedbehindapaywall?Yournextstepwaslikely

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Achieving telehealth equity for people with hearing loss

          AdobeGenZhasmadecaptioningcool.Captionsarenowwidelyavailableinsocialmedia,entertainmentchannels,andw